BBC

Virtus LifeSci Biotech Clinical Trials ETF
*Unless otherwise stated, data provided by FactSet.

BBC Fund Description

BBC tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials.

BBC Factset Analytics Insight

BBC focuses on biotech companies with lead drugs that are still in various phases of clinical trials and not yet approved marketing. Given the low historical success rates in clinical trials, the fund is a high-risk and high-reward bet on a small subset of biotech companies. It excludes companies with a lead drug candidate that’s still in preclinical testing or research stage, prior to entering into human clinical trials. Also excluded are the following 12 distinct sub-industries: Animal Health, Diversified Healthcare, Investment Management, Healthcare Services, Non-Healthcare, Large Pharmaceuticals, Specialty Pharmaceuticals, Medical Devices, Vaccines, Nutraceuticals, OTC Healthcare, or Tools. As such, investors looking for broad biotech exposure, won't find it in BBC. The Index Committee utilizes various public data sources to select portfolio holdings, including, SEC filings, public documents from the U.S. FDA, company press releases and official corporate websites.

BBC MSCI ESG Analytics Insight

Virtus LifeSci Biotech Clinical Trials ETF has an MSCI ESG Fund Rating of BB based on a score of 4.02 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Virtus LifeSci Biotech Clinical Trials ETF ranks in the 11st percentile within its peer group and in the 23th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

BBC MSCI FaCS and Factor Box

MSCI FaCS is a standard method for evaluating and reporting the Factor characteristics of equity portfolios including ETFs. The Factor Box includes 6 Factors that MSCI has identified that historically provided a return premium. On the vertical axis, the Factor Groups, are displayed and the horizontal axis displays the Factor exposure, overweight, underweight or neutral.

PERFORMANCE [as of 09/15/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
BBC 4.14% -9.38% -4.98% 15.43% 11.58% 17.38% --
BBC (NAV) 5.26% -6.04% -4.15% 16.21% 18.55% 4.83% --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

BBC Summary Data

Virtus
12/16/14
Open-Ended Fund
0.79%
$37.69M
$139.30K
0.21%

BBC Portfolio Data

$1.81B
-7.37
3.67
1.24%
N/A
192

BBC Index Data

Equal
Proprietary
N/A

BBC Portfolio Management

0.79%
-1.80%
-0.62%
-4.69%

BBC Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

BBC Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
High
Daily

BBC Factset Analytics Block Liquidity

As of 09/16/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of BBC. BBC is rated a 4 out of 5.

BBC Tradability

3,012
$139.30K
2,649
$124.27K
0.21%
$0.10
-0.13%
0.48% / -0.50%
None
86.00%
50,000
0.05
0.02%
0.29%
0
$47.68
4

BBC Top 10 Holdings[View All]

1.36%
1.32%
11.63%

BBC Countries


BBC
Segment Benchmark
95.16%
--
2.48%
--
1.82%
--
0.54%
--

BBC Regions


BBC
Segment Benchmark
95.16%
--
3.02%
--
1.82%
--

BBC Economic Development


BBC
Segment Benchmark
98.18%
--
1.82%
--

BBC Performance Statistics

--
--
--
--
0.00%
N/A

BBC MSCI ESG Ratings

4.02 / 10
22.66
10.88
--
1.81%
25.87

BBC Benchmark Comparison Holdings

192
--
--
0.00%

BBC Benchmark Comparison Summary


BBC
Segment Benchmark
192
--
$1.81B
--
-7.37
--
3.67
--
0.09%
--
Low
High

BBC Benchmark Comparison Market Cap Size


BBC
Segment Benchmark
0.53%
--
17.84%
--
56.03%
--
25.60%
--